학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

Document Type

Article

Author

Rewerska, B.; Sher, L.D.; Alpizar, S.; Pauser, S.; Pulka, G.; Mozaffarian, N.; Salhi, Y.; Jabert, W.; Gudi, G.; CA, V.; Macoin, J.; Anstett, V.; Turrini, R.; Doucey, M.-A.; Blein, S.; Konto, C.; Martinet, C.; GN, S.; Machkova, M.

Source

In: Journal of Allergy and Clinical Immunology: Global. (Journal of Allergy and Clinical Immunology: Global, February 2024, 3(1))

Subject

Language

English

ISSN

27728293

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Scopus Find it@PNU

이메일